Coherus Oncology, Inc. (CHRS)
1.71
+0.08
(+4.91%)
USD |
NASDAQ |
Feb 19, 16:00
1.74
+0.03
(+1.75%)
Pre-Market: 09:26
Coherus Oncology Shareholders Equity (Quarterly) : 87.77M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Allogene Therapeutics, Inc. | 315.33M |
| Vertex Pharmaceuticals, Inc. | 18.67B |
| CorMedix, Inc. | 374.13M |
| Verastem, Inc. | -15.53M |
| Anavex Life Sciences Corp. | 126.62M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 516.52M |
| Total Liabilities (Quarterly) | 428.74M |
| Debt to Equity Ratio | 0.6189 |
| Current Ratio | 1.238 |
| Net Debt Paydown Yield | 25.60% |